CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 44 filers reported holding CHEMBIO DIAGNOSTICS INC in Q4 2021. The put-call ratio across all filers is 5.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $68,000 | -69.6% | 83,450 | -57.4% | 0.04% | -67.4% |
| Q4 2021 | $224,000 | -74.7% | 196,110 | -44.7% | 0.14% | -75.5% |
| Q3 2021 | $887,000 | -15.9% | 354,670 | -0.2% | 0.55% | -12.8% |
| Q2 2021 | $1,055,000 | -13.9% | 355,270 | +1.8% | 0.63% | -28.3% |
| Q1 2021 | $1,225,000 | -25.0% | 348,960 | +1.4% | 0.88% | -29.9% |
| Q4 2020 | $1,634,000 | -1.9% | 344,060 | +0.4% | 1.26% | -12.8% |
| Q3 2020 | $1,666,000 | +130.7% | 342,760 | +54.2% | 1.44% | +103.4% |
| Q2 2020 | $722,000 | -28.6% | 222,220 | +12.5% | 0.71% | -45.2% |
| Q1 2020 | $1,011,000 | +35.5% | 197,560 | +20.7% | 1.30% | +78.1% |
| Q4 2019 | $746,000 | -1.6% | 163,640 | +32.0% | 0.73% | -11.6% |
| Q3 2019 | $758,000 | -0.8% | 123,950 | -1.2% | 0.82% | +0.2% |
| Q2 2019 | $764,000 | +7.8% | 125,450 | -1.7% | 0.82% | +11.3% |
| Q1 2019 | $709,000 | – | 127,650 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Penbrook Management LLC | 344,060 | $1,634,000 | 1.26% |
| Union Square Park Capital Management, LLC | 400,000 | $1,900,000 | 0.76% |
| P.A.W. CAPITAL CORP | 100,000 | $475,000 | 0.42% |
| PRECEPT MANAGEMENT LLC | 150,000 | $713,000 | 0.29% |
| Newbridge Financial Services Group, Inc. | 73,500 | $349,000 | 0.29% |
| SANDERS MORRIS HARRIS LLC | 183,584 | $990,000 | 0.22% |
| FRIESS ASSOCIATES LLC | 555,000 | $2,636,000 | 0.19% |
| PERRITT CAPITAL MANAGEMENT INC | 30,651 | $146,000 | 0.09% |
| Ikarian Capital, LLC | 219,109 | $1,041,000 | 0.05% |
| SEGALL BRYANT & HAMILL, LLC | 705,823 | $3,352,000 | 0.04% |